Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the Imbrave150 Trial Inclusion Criteria Impact Prognosis?

AuthID
P-00Y-467
70
Author(s)
Rimini, M
·
[+4]·
[+2]·
[+3]·
[+2]·
[+8]·
[+3]·
[+1]·
[+1]·
[+3]·
[+5]·
[+2]·
[+1]·
[+3]·
[+1]·
[+4]·
[+4]·
Casadei-Gardini, A
Document Type
Article in Press
Year published
2023
Published
in TARGETED ONCOLOGY, ISSN: 1776-2596
Indexing
Publication Identifiers
Pubmed: 36920648
Scopus: 2-s2.0-85149919940
Wos: WOS:000950092300001
Source Identifiers
ISSN: 1776-2596
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Rimini, M;   2 Persano, M;   3 Tada, T;
4 Suda, G;   5 Shimose, S;   6 Kudo, M;
7 Cheon, J;   8 Finkelmeier, F;   9 Lim, HY;
10 Presa, J;   11 Masi, G;   12 Yoo, C;
13 Lonardi, S;   14 Piscaglia, F;   15 Kumada, T;
16 Sakamoto, N;   17 Iwamoto, H;   18 Aoki, T;
19 Chon, HJ;   20 Himmelsbach, V;   21 Pressiani, T;
22 Montes, M;   23 Vivaldi, C;   24 Solda, C;
25 Hiraoka, A;   26 Sho, T;   27 Niizeki, T;
28 Nishida, N;   29 Steup, C;   30 Hirooka, M;
31 Kariyama, K;   32 Tani, J;   33 Atsukawa, M;
34 Takaguchi, K;   35 Itobayashi, E;   36 Fukunishi, S;
37 Tsuji, K;   38 Ishikawa, T;   39 Tajiri, K;
40 Ochi, H;   41 Yasuda, S;   42 Toyoda, H;
43 Ogawa, C;   44 Nishimura, T;   45 Hatanaka, T;
46 Kakizaki, S;   47 Shimada, N;   48 Kawata, K;
49 Tada, F;   50 Ohama, H;   51 Nouso, K;
52 Morishita, A;   53 Tsutsui, A;   54 Nagano, T;
55 Itokawa, N;   56 Okubo, T;   57 Arai, T;
58 Imai, M;   59 Kosaka, H;   60 Naganuma, A;
61 Koizumi, Y;   62 Nakamura, S;   63 Kaibori, M;
64 Iijima, H;   65 Hiasa, Y;   66 Burgio, V;
67 Rimassa, L;   68 Scartozzi, M;   69 Cascinu, S;
70 Casadei-Gardini, A;